Pfizer unblinds placebo control arm of trial group

On December 14, 2020 Pfizer/BioNTech removes the saline placebo control arm (unblinds) of their Phase 3 clinical trial, just 3 days after FDA issues Emergency Use Authorisation (EUA) for Pfizer-BioNTech COVID-19 vaccine.  This unblinding  of the control group by offering the trial participants the option to take the treatment product (the vaccine) eliminates the true ability to conduct legitimate long term safety studies.

• Dec 14, 2020 – Pfizer eliminates the placebo control clinical trial group
• Jan 14, 2021 – Moderna eliminates the placebo control clinical trial group

Under EUA these new products referred to as ‘vaccines’ are still undergoing data collection and thus are experimental.  Placebo control safety data has now been compromised as the control group get the treatment. [1]

By March 2021 FOIA documents show 90% of placebo group had received at least one mRNA shot – i.e. “Pfizer stopped collecting useful data long before the planned end date of the clinical trial.”